Heidi J Coher, PA | |
8607 E Us Highway 36 # 100, Avon, IN 46123-7960 | |
(317) 208-3866 | |
(317) 208-3867 |
Full Name | Heidi J Coher |
---|---|
Gender | Female |
Speciality | Physician Assistant |
Experience | 14 Years |
Location | 8607 E Us Highway 36 # 100, Avon, Indiana |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1386934982 | NPI | - | NPPES |
10001266 | Other | IN | PA |
P01291686 | Other | IN | RAILROAD MEDICARE |
300005200 | Medicaid | IN | |
99046364A | Other | IN | INDIANA MEDICAL LICENSING AGENCY |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363A00000X | Physician Assistant | 10001266A (Indiana) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Riverview Health | Noblesville, IN | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
American Health Network Of Indiana Llc | 9830093533 | 212 |
News Archive
Starpharma Holdings Limited has announced that a full licence agreement has been signed with SSL International plc in relation to the VivaGel coated condom. SSL manufactures and sells Durex condoms, the market-leading condom brand worldwide.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the launches and widespread uptake of novel oral anticoagulants will drive the venous thromboembolism drug market to nearly double from $2.9 billion in 2008 to more than $5 billion in 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
BHR Pharma, LLC announced today the European Medicines Agency (EMA), responsible for evaluating medicines developed for use in the European Union, granted an orphan medicinal product designation for treating moderate and severe traumatic brain injury (TBI) to its proprietary intravenous progesterone infusion agent, BHR-100. The agent currently is being evaluated as a neuroprotective treatment for severe traumatic brain injury (TBI) in the global, Phase III SyNAPSe® clinical trial.
Targeting the neuroinflammatory causes of Parkinson's disease with a naturally present brain chemical signal could offer a better understanding of the clinical mechanisms of the disease and open a future therapeutic window, reports a team of researchers from the University of South Florida Department Neurosurgery and Brain Repair and the James A. Haley Veterans' Administration Hospital, Tampa.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Heidi J Coher, PA 8607 E Us Highway 36 # 100, Avon, IN 46123-7960 Ph: (317) 208-3866 | Heidi J Coher, PA 8607 E Us Highway 36 # 100, Avon, IN 46123-7960 Ph: (317) 208-3866 |
News Archive
Starpharma Holdings Limited has announced that a full licence agreement has been signed with SSL International plc in relation to the VivaGel coated condom. SSL manufactures and sells Durex condoms, the market-leading condom brand worldwide.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the launches and widespread uptake of novel oral anticoagulants will drive the venous thromboembolism drug market to nearly double from $2.9 billion in 2008 to more than $5 billion in 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
BHR Pharma, LLC announced today the European Medicines Agency (EMA), responsible for evaluating medicines developed for use in the European Union, granted an orphan medicinal product designation for treating moderate and severe traumatic brain injury (TBI) to its proprietary intravenous progesterone infusion agent, BHR-100. The agent currently is being evaluated as a neuroprotective treatment for severe traumatic brain injury (TBI) in the global, Phase III SyNAPSe® clinical trial.
Targeting the neuroinflammatory causes of Parkinson's disease with a naturally present brain chemical signal could offer a better understanding of the clinical mechanisms of the disease and open a future therapeutic window, reports a team of researchers from the University of South Florida Department Neurosurgery and Brain Repair and the James A. Haley Veterans' Administration Hospital, Tampa.
› Verified 1 days ago
Kimberly Keyes Barrett, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1111 Ronald Reagan Pkwy, Avon, IN 46123 Phone: 260-433-1314 | |
Timothy W Johnson, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1111 Ronald Reagan Pkwy, Avon, IN 46123 Phone: 317-472-7317 Fax: 317-870-0499 | |
Kelly L Foutch, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 8607 E Us Highway 36 Ste 300, Avon, IN 46123 Phone: 317-718-7960 | |
Zoie Evelyn Cason, Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 8244 E Us Highway 36 Ste 1100, Avon, IN 46123 Phone: 317-272-7500 Fax: 317-272-7515 | |
Adam Jones, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1111 Ronald Reagan Pkwy, Avon, IN 46123 Phone: 317-217-3000 | |
Ms. Jennifer Elaine Davis, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 1111 Ronald Reagan Pkwy, Avon, IN 46123 Phone: 317-217-3000 Fax: 317-963-5492 | |
Morgan Wade Hughes, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1115 Ronald Reagan Pkwy Ste 141, Avon, IN 46123 Phone: 317-217-2300 |